GlassScriptPhysician profile
Debora S Sedaghat
NPI 1578619243
$586.21
in general payments reported to CMS, 2019-2025
14 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.45 · 2021: $68.53 · 2022: $181 · 2023: $125 · 2024: $6.88 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $178.66 | 2023-2025 | Myfembree |
| Abbvie INC. | $80.65 | 2019-2022 | |
| Hologic Sales and Service, LLC | $53.79 | 2022-2025 | Omni Hysteroscope, Novasure, Myosure Tissue Removal Device |
| Allergan, INC. | $42.89 | 2019 | |
| Organon LLC | $35.34 | 2022-2024 | |
| Biogen, INC. | $27.82 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $27.64 | 2022 | |
| Mayne Pharma Commercial LLC | $27.28 | 2021 | |
| Exeltis, USA INC. | $23.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.56 | 2022 | |
| Avanos Medical | $21.00 | 2019 | |
| Pfizer INC. | $17.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.94 | 2019 | |
| Avion Pharmaceuticals | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debora Sedaghat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.